(RoyalPatriot.com )- The “Late Show” talk show host Stephen Colbert contracted COVID for the second time in three weeks, but he touted the vaccine’s efficacy. When he contracted the virus last month on April 21, which forced him to miss that night’s taping before taking a week off,
he touted the vaccine’s efficacy then, too.
Colbert said on social media at the time that he was feeling fine and grateful to be “vaxxed and boosted.” He updated viewers a few days later, saying he had a severe head cold and that his illness had not been fun.
According to a report, the Late Show musical director Jon Batiste tested positive a few days later. Jon Batiste, Colbert’s Grammy-winning bandleader, explained on Instagram that he had tested positive for COVID, and his long-awaited “American Symphony” event at Carnegie Hall in New York would be postponed. Previously, Batiste attended the Met Gala with his wife, author Suleika Jaouad, who is undergoing cancer treatment with chemotherapy.
James Corden, Seth Meyers, and Jimmy Kimmel are among the other late-night hosts who have lately tested positive for the virus.
The Late Show premiered fresh episodes on May 2nd. However, production has since been halted due to reports of Colbert’s recurrence of COVID-19.
The official ‘The Late Show’ Twitter account tweeted that Colbert was having symptoms associated with a relapse of COVID and that he would be isolated for a few more days out of caution for his staff, visitors, and audience. Until further notice, new episodes of The Late Show will not be taped, the Tweet explained.
According to studies, there are doubts about the vaccine’s efficacy and how long its protection lasts. The vaccine’s power begins to decline after approximately four months, according to a report released by the Centers for Disease Control and Prevention (CDC) in February 2022.
Pfizer’s new drug, Paxlovid, is a relatively new weapon in the fight against COVID.
The manufacturer touts its effectiveness against severe COVID infection in adults. However, the Associated Press reports that patients may be prone to relapse after taking the treatment.
Oh well. Maybe the next drug will work. Or the one after that…